Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Barlier

Showing results (101-110 of 166) with videos related to

Pageof 17
Sort By:
The Journal of Clinical Endocrinology and Metabolism|April 13, 2026
3D volume growth rate may open new perspectives for the classification of aggressive pituitary adenomasThomas Graillon, Emeline Tabouret, Romain Appay, et al.
The Journal of Clinical Endocrinology and Metabolism|March 18, 2010
A potential inhibitory role for the new truncated variant of somatostatin receptor 5, sst5TMD4, in pituitary adenomas poorly responsive to somatostatin analogsMario Durán-Prado, Alexandru Saveanu, Raul M Luque, et al.
The Journal of Clinical Endocrinology and Metabolism|October 21, 2011
Deficit in anterior pituitary function and variable immune deficiency (DAVID) in children presenting with adrenocorticotropin deficiency and severe infectionsMarie-Hélène Quentien, Brigitte Delemer, Dimitris T Papadimitriou, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2009
18F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature?David Taïeb, Frederic Sebag, Anne Barlier, et al.
Endocrine Connections|September 16, 2022
Systematic detection of mosaicism by using digital NGS reveals three new MEN1 mosaicismsArnaud Lagarde, Grégory Mougel, Lucie Coppin, et al.
European Journal of Human Genetics : EJHG|March 13, 2015
European guidance for the molecular diagnosis of pseudohypoparathyroidism not caused by point genetic variants at GNAS: an EQA studyIntza Garin, Giovanna Mantovani, Urko Aguirre, et al.
European Journal of Human Genetics : EJHG|July 10, 2014
European guidance for the molecular diagnosis of pseudohypoparathyroidism not caused by point genetic variants at GNAS: an EQA studyIntza Garin, Giovanna Mantovani, Urko Aguirre, et al.
Neuro-Oncology|February 8, 2021
Role of 3D volume growth rate for drug activity evaluation in meningioma clinical trials: the example of the CEVOREM studyThomas Graillon, Loic Ferrer, Jason Siffre, et al.
Human Mutation|March 15, 2019
Proposition of adjustments to the ACMG-AMP framework for the interpretation of MEN1 missense variantsPauline Romanet, Marie-Françoise Odou, Marie-Odile North, et al.
The Journal of Clinical Endocrinology and Metabolism|October 20, 2018
UMD-MEN1 Database: An Overview of the 370 MEN1 Variants Present in 1676 Patients From the French PopulationPauline Romanet, Amira Mohamed, Sophie Giraud, et al.
Pageof 17

Showing results (101-110 of 166) with videos related to

Sort By:
Pageof 17
The Journal of Clinical Endocrinology and Metabolism|April 13, 2026
3D volume growth rate may open new perspectives for the classification of aggressive pituitary adenomasThomas Graillon, Emeline Tabouret, Romain Appay, et al.
The Journal of Clinical Endocrinology and Metabolism|March 18, 2010
A potential inhibitory role for the new truncated variant of somatostatin receptor 5, sst5TMD4, in pituitary adenomas poorly responsive to somatostatin analogsMario Durán-Prado, Alexandru Saveanu, Raul M Luque, et al.
The Journal of Clinical Endocrinology and Metabolism|October 21, 2011
Deficit in anterior pituitary function and variable immune deficiency (DAVID) in children presenting with adrenocorticotropin deficiency and severe infectionsMarie-Hélène Quentien, Brigitte Delemer, Dimitris T Papadimitriou, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2009
18F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature?David Taïeb, Frederic Sebag, Anne Barlier, et al.
Endocrine Connections|September 16, 2022
Systematic detection of mosaicism by using digital NGS reveals three new MEN1 mosaicismsArnaud Lagarde, Grégory Mougel, Lucie Coppin, et al.
European Journal of Human Genetics : EJHG|March 13, 2015
European guidance for the molecular diagnosis of pseudohypoparathyroidism not caused by point genetic variants at GNAS: an EQA studyIntza Garin, Giovanna Mantovani, Urko Aguirre, et al.
European Journal of Human Genetics : EJHG|July 10, 2014
European guidance for the molecular diagnosis of pseudohypoparathyroidism not caused by point genetic variants at GNAS: an EQA studyIntza Garin, Giovanna Mantovani, Urko Aguirre, et al.
Neuro-Oncology|February 8, 2021
Role of 3D volume growth rate for drug activity evaluation in meningioma clinical trials: the example of the CEVOREM studyThomas Graillon, Loic Ferrer, Jason Siffre, et al.
Human Mutation|March 15, 2019
Proposition of adjustments to the ACMG-AMP framework for the interpretation of MEN1 missense variantsPauline Romanet, Marie-Françoise Odou, Marie-Odile North, et al.
The Journal of Clinical Endocrinology and Metabolism|October 20, 2018
UMD-MEN1 Database: An Overview of the 370 MEN1 Variants Present in 1676 Patients From the French PopulationPauline Romanet, Amira Mohamed, Sophie Giraud, et al.
Pageof 17